Novartis Pharma AG: Novartis shareholders approve the proposed 100% Spin-off of Sandoz finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Sandoz publishes supplement to Listing Prospectus including Sandoz H1 2023 financial statements finanzen.at - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.at Daily Mail and Mail on Sunday newspapers.
There are currently supply bottlenecks for around 500 medicines, including the antibiotic penicillin. Every second box of the active ingredient in Europe comes directly or indirectly from one place: a factory in the Tyrolean town of Kundl, Austria. Die Welt takes a look at the factory and what's causing the supply problems.
Ad hoc announcement pursuant to Art. 53 LR U.S. District Court for the District of Delaware ruled the Entresto (sacubitril / valsartan) ‘combination patent’ to be invalid Novartis will appeal to the U.S. Court of Appeals for the Federal Circuit to reverse the District Court’s rulingNo generic Entresto product has received FDA approval as of todayPending a final appeal decision and other ongoing litigation involving multiple patents, any launch once generics receive FDA approval would be ‘at risk